![]() |
Volumn 360, Issue 9329, 2002, Pages 319-326
|
Suicide
|
Author keywords
[No Author keywords available]
|
Indexed keywords
5 HYDROXYINDOLEACETIC ACID;
ALPRAZOLAM;
AMFEBUTAMONE;
AMITRIPTYLINE;
AMOXAPINE;
ANTIDEPRESSANT AGENT;
ANXIOLYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BIOLOGICAL MARKER;
BUSPIRONE;
CITALOPRAM;
CLOMIPRAMINE;
DESIPRAMINE;
DOXEPIN;
FLUOXETINE;
FLUVOXAMINE;
IMIPRAMINE;
LORAZEPAM;
MAPROTILINE;
MIRTAZAPINE;
NEFAZODONE;
NEUROLEPTIC AGENT;
NORTRIPTYLINE;
PHENELZINE;
SEROTONIN;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TRANYLCYPROMINE;
UNINDEXED DRUG;
VENLAFAXINE;
AFFECTIVE NEUROSIS;
BECK DEPRESSION INVENTORY;
BEHAVIOR THERAPY;
BIOLOGY;
CEREBROSPINAL FLUID;
COGNITIVE THERAPY;
ELECTROCONVULSIVE THERAPY;
GENETICS;
HAMILTON SCALE;
HOSPITAL ADMISSION;
HUMAN;
NEUROCHEMISTRY;
PREDICTION;
PRIORITY JOURNAL;
PSYCHIATRIC DIAGNOSIS;
PSYCHOTHERAPY;
REVIEW;
RISK FACTOR;
SEROTONIN METABOLISM;
SOCIOBIOLOGY;
SUICIDE;
|
EID: 0037183246
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(02)09556-9 Document Type: Review |
Times cited : (300)
|
References (55)
|